seaforth life sciences ltd
seaforth life sciences ltd Company Information
Company Number
10589726
Next Accounts
Jan 2026
Directors
Shareholders
seaforth land holdings limited
Group Structure
View All
Industry
Management of real estate on a fee or contract basis
Registered Address
29-31 saffron hill, london, london, EC1N 8SW
Website
www.seaforthland.comseaforth life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of SEAFORTH LIFE SCIENCES LTD at £30.9k based on a Turnover of £19.8k and 1.56x industry multiple (adjusted for size and gross margin).
seaforth life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of SEAFORTH LIFE SCIENCES LTD at £0 based on an EBITDA of £0 and a 4.11x industry multiple (adjusted for size and gross margin).
seaforth life sciences ltd Estimated Valuation
Pomanda estimates the enterprise value of SEAFORTH LIFE SCIENCES LTD at £1 based on Net Assets of £1 and 1.82x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Seaforth Life Sciences Ltd Overview
Seaforth Life Sciences Ltd is a live company located in london, EC1N 8SW with a Companies House number of 10589726. It operates in the management of real estate on a fee or contract basis sector, SIC Code 68320. Founded in January 2017, it's largest shareholder is seaforth land holdings limited with a 100% stake. Seaforth Life Sciences Ltd is a young, micro sized company, Pomanda has estimated its turnover at £19.8k with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Seaforth Life Sciences Ltd Health Check
Pomanda's financial health check has awarded Seaforth Life Sciences Ltd a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 4 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
4 Weak
Size
annual sales of £19.8k, make it smaller than the average company (£378.1k)
- Seaforth Life Sciences Ltd
£378.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (6.3%)
- Seaforth Life Sciences Ltd
6.3% - Industry AVG
Production
with a gross margin of 15.8%, this company has a higher cost of product (68.7%)
- Seaforth Life Sciences Ltd
68.7% - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- Seaforth Life Sciences Ltd
- - Industry AVG
Employees
with 1 employees, this is below the industry average (6)
1 - Seaforth Life Sciences Ltd
6 - Industry AVG
Pay Structure
on an average salary of £40.6k, the company has an equivalent pay structure (£40.6k)
- Seaforth Life Sciences Ltd
£40.6k - Industry AVG
Efficiency
resulting in sales per employee of £19.8k, this is less efficient (£102.8k)
- Seaforth Life Sciences Ltd
£102.8k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (50 days)
- Seaforth Life Sciences Ltd
50 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Seaforth Life Sciences Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Seaforth Life Sciences Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Seaforth Life Sciences Ltd
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Seaforth Life Sciences Ltd
- - Industry AVG
SEAFORTH LIFE SCIENCES LTD financials
Seaforth Life Sciences Ltd's latest turnover from April 2024 is estimated at £19.8 thousand and the company has net assets of £1. According to their latest financial statements, Seaforth Life Sciences Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|---|
| Turnover | |||||||
| Other Income Or Grants | |||||||
| Cost Of Sales | |||||||
| Gross Profit | |||||||
| Admin Expenses | |||||||
| Operating Profit | |||||||
| Interest Payable | |||||||
| Interest Receivable | |||||||
| Pre-Tax Profit | |||||||
| Tax | |||||||
| Profit After Tax | |||||||
| Dividends Paid | |||||||
| Retained Profit | |||||||
| Employee Costs | |||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||
| Intangible Assets | |||||||
| Investments & Other | |||||||
| Debtors (Due After 1 year) | |||||||
| Total Fixed Assets | |||||||
| Stock & work in progress | |||||||
| Trade Debtors | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Group Debtors | |||||||
| Misc Debtors | |||||||
| Cash | |||||||
| misc current assets | |||||||
| total current assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| total assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Bank overdraft | |||||||
| Bank loan | |||||||
| Trade Creditors | |||||||
| Group/Directors Accounts | |||||||
| other short term finances | |||||||
| hp & lease commitments | |||||||
| other current liabilities | |||||||
| total current liabilities | |||||||
| loans | |||||||
| hp & lease commitments | |||||||
| Accruals and Deferred Income | |||||||
| other liabilities | |||||||
| provisions | |||||||
| total long term liabilities | |||||||
| total liabilities | |||||||
| net assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| total shareholders funds | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Profit | |||||||
| Depreciation | |||||||
| Amortisation | |||||||
| Tax | |||||||
| Stock | |||||||
| Debtors | 1 | ||||||
| Creditors | |||||||
| Accruals and Deferred Income | |||||||
| Deferred Taxes & Provisions | |||||||
| Cash flow from operations | |||||||
| Investing Activities | |||||||
| capital expenditure | |||||||
| Change in Investments | |||||||
| cash flow from investments | |||||||
| Financing Activities | |||||||
| Bank loans | |||||||
| Group/Directors Accounts | |||||||
| Other Short Term Loans | |||||||
| Long term loans | |||||||
| Hire Purchase and Lease Commitments | |||||||
| other long term liabilities | |||||||
| share issue | |||||||
| interest | |||||||
| cash flow from financing | |||||||
| cash and cash equivalents | |||||||
| cash | |||||||
| overdraft | |||||||
| change in cash |
seaforth life sciences ltd Credit Report and Business Information
Seaforth Life Sciences Ltd Competitor Analysis
Perform a competitor analysis for seaforth life sciences ltd by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other micro companies, companies in EC1N area or any other competitors across 12 key performance metrics.
seaforth life sciences ltd Ownership
SEAFORTH LIFE SCIENCES LTD group structure
Seaforth Life Sciences Ltd has no subsidiary companies.
Ultimate parent company
1 parent
SEAFORTH LIFE SCIENCES LTD
10589726
seaforth life sciences ltd directors
Seaforth Life Sciences Ltd currently has 1 director, Mr Tyler Goodwin serving since Jan 2017.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Tyler Goodwin | England | 57 years | Jan 2017 | - | Director |
P&L
April 2024turnover
19.8k
+8%
operating profit
0
0%
gross margin
15.8%
-10.92%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
April 2024net assets
1
0%
total assets
1
0%
cash
0
0%
net assets
Total assets minus all liabilities
seaforth life sciences ltd company details
company number
10589726
Type
Private limited with Share Capital
industry
68320 - Management of real estate on a fee or contract basis
incorporation date
January 2017
age
8
incorporated
UK
ultimate parent company
accounts
Dormant
last accounts submitted
April 2024
previous names
seaforth land management limited (May 2022)
accountant
STERLING
auditor
-
address
29-31 saffron hill, london, london, EC1N 8SW
Bank
-
Legal Advisor
-
seaforth life sciences ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to seaforth life sciences ltd.
seaforth life sciences ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SEAFORTH LIFE SCIENCES LTD. This can take several minutes, an email will notify you when this has completed.
seaforth life sciences ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
